scispace - formally typeset
H

Hirofumi Tani

Researcher at Hokkaido University

Publications -  93
Citations -  1920

Hirofumi Tani is an academic researcher from Hokkaido University. The author has contributed to research in topics: Micelle & Liposome. The author has an hindex of 18, co-authored 86 publications receiving 1444 citations.

Papers
More filters
Journal ArticleDOI

Micelle-mediated extraction

TL;DR: In this paper, the phase behavior of aqueous micellar solutions and recent advances in the phase separation technique are described, and the recent use of affinity ligands and water-soluble polymers for controlling extractability of proteins are also introduced.
Journal ArticleDOI

Advances in Microfluidic Paper-Based Analytical Devices for Food and Water Analysis.

TL;DR: Recently reported microfluidic paper-based analytical devices that incorporate different detection methods such as colorimetric, electrochemical, fluorescence, chemiluminescence, and electrochemilumineinescence techniques for food and water analysis are reviewed.
Journal ArticleDOI

Aqueous Micellar Two-Phase Systems for Protein Separation

TL;DR: In this paper, a two-phase separation of aqueous micellar solution (AMTPS) was proposed for protein purification, which consists of a surfactantdepleted phase (aqueous phase) and a surfactant-rich phase (surfactant rich phase).
Journal ArticleDOI

Development of the iLiNP Device: Fine Tuning the Lipid Nanoparticle Size within 10 nm for Drug Delivery.

TL;DR: This work developed a baffle mixer device named the invasive lipid nanoparticle production device, or iLiNP device for short, which has a simple two-dimensional microchannel and mixer structure and achieved the first reported LNP size tuning at 10 nm intervals in the size range from 20 to 100 nm.
Journal ArticleDOI

Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers.

TL;DR: The precise size-controlled LNPs produced by the microfluidic devices are expected to become carriers for next generation nanomedicines and they will lead to new and effective approaches for cancer treatment.